These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24661544)

  • 1. Analysis of melanoma-related microRNAs expression during the spontaneous regression of cutaneous melanomas in MeLiM pigs.
    Baco M; Chu CY; Bouet S; Rogel-Gaillard C; Bourneuf E; Le Provost F; Chu CY; Vincent-Naulleau S
    Pigment Cell Melanoma Res; 2014 Jul; 27(4):668-70. PubMed ID: 24661544
    [No Abstract]   [Full Text] [Related]  

  • 2. MicroRNAs in malignant melanoma.
    Völler D; Ott C; Bosserhoff A
    Clin Biochem; 2013 Jul; 46(10-11):909-17. PubMed ID: 23360785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PROONCOGENIC EFFECTS OF INHIBITING THE microRNA miR-106A IN SKIN MELANOMA CELLS IN VITRO.
    Palkina NV; Komina AV; Aksenenko MB; Ruksha TG
    Tsitologiia; 2016; 58(9):679-87. PubMed ID: 30198679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
    Li Y; Li M; Shats I; Krahn JM; Flake GP; Umbach DM; Li X; Li L
    PLoS One; 2019; 14(6):e0218067. PubMed ID: 31199813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant features of minipig melanomas prior to spontaneous regression.
    Débare H; Blanc F; Piton G; Leplat JJ; Vincent-Naulleau S; Rivière J; Vilotte M; Marthey S; Lecardonnel J; Coville JL; Estellé J; Rau A; Bourneuf E; Egidy G
    Sci Rep; 2024 Apr; 14(1):9240. PubMed ID: 38649394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription analysis in the MeLiM swine model identifies RACK1 as a potential marker of malignancy for human melanocytic proliferation.
    Egidy G; Julé S; Bossé P; Bernex F; Geffrotin C; Vincent-Naulleau S; Horak V; Sastre-Garau X; Panthier JJ
    Mol Cancer; 2008 Apr; 7():34. PubMed ID: 18442364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. sPAGM: inferring subpathway activity by integrating gene and miRNA expression-robust functional signature identification for melanoma prognoses.
    Zhang CL; Xu YJ; Yang HX; Xu YQ; Shang DS; Wu T; Zhang YP; Li X
    Sci Rep; 2017 Nov; 7(1):15322. PubMed ID: 29127397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite regulation of tenascin-C and tenascin-X in MeLiM swine heritable cutaneous malignant melanoma.
    Geffrotin C; Horak V; Créchet F; Tricaud Y; Lethias C; Vincent-Naulleau S; Vielh P
    Biochim Biophys Acta; 2000 Dec; 1524(2-3):196-202. PubMed ID: 11113568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis.
    Lohcharoenkal W; Das Mahapatra K; Pasquali L; Crudden C; Kular L; Akkaya Ulum YZ; Zhang L; Xu Landén N; Girnita L; Jagodic M; Ståhle M; Sonkoly E; Pivarcsi A
    J Invest Dermatol; 2018 Apr; 138(4):882-892. PubMed ID: 29104160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of differentially expressed genes in spontaneously regressing melanoma using the MeLiM swine model.
    Rambow F; Malek O; Geffrotin C; Leplat JJ; Bouet S; Piton G; Hugot K; Bevilacqua C; Horak V; Vincent-Naulleau S
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):147-61. PubMed ID: 18426408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-221 and -222 pathway controls melanoma progression.
    Felicetti F; Errico MC; Segnalini P; Mattia G; Carè A
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1759-65. PubMed ID: 18983236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA miR-125b induces senescence in human melanoma cells.
    Glud M; Manfé V; Biskup E; Holst L; Dirksen AM; Hastrup N; Nielsen FC; Drzewiecki KT; Gniadecki R
    Melanoma Res; 2011 Jun; 21(3):253-6. PubMed ID: 21460750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.
    Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q
    Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIT and melanoma predisposition in pigs: sequence variants and association analysis.
    Fernández-Rodríguez A; Estellé J; Blin A; Muñoz M; Créchet F; Demenais F; Vincent-Naulleau S; Bourneuf E
    Anim Genet; 2014 Jun; 45(3):445-8. PubMed ID: 24628300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A marker for melanoma?
    Chande M
    Lancet; 2001 Aug; 358(9281):565. PubMed ID: 11520537
    [No Abstract]   [Full Text] [Related]  

  • 16. No evidence for c-erbB-2 overexpression in cutaneous melanoma.
    Fink-Puches R; Pilarski P; Schmidbauer U; Kerl H; Soyer HP
    Anticancer Res; 2001; 21(4A):2793-5. PubMed ID: 11724356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pivotal MicroRNAs in Melanoma: A Mini-Review.
    Deng Z; Hao J; Lei D; He Y; Lu L; He L
    Mol Diagn Ther; 2016 Oct; 20(5):449-55. PubMed ID: 27351922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disturbed protein-protein interaction networks in metastatic melanoma are associated with worse prognosis and increased functional mutation burden.
    Schramm SJ; Li SS; Jayaswal V; Fung DC; Campain AE; Pang CN; Scolyer RA; Yang YH; Mann GJ; Wilkins MR
    Pigment Cell Melanoma Res; 2013 Sep; 26(5):708-22. PubMed ID: 23738911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma.
    Goydos JS; Gorski DH
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5962-7. PubMed ID: 14676121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathogenesis of cutaneous melanocytic neoplasms.
    Ibrahim N; Haluska FG
    Annu Rev Pathol; 2009; 4():551-79. PubMed ID: 19400696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.